TY - JOUR AU - Carbone, M. AU - Yang, H. PY - 2017 DA - 2017// TI - Mesothelioma: recent highlights JO - Ann Transl Med VL - 5 UR - https://doi.org/10.21037/atm.2017.04.29 DO - 10.21037/atm.2017.04.29 ID - Carbone2017 ER - TY - JOUR AU - Mairinger, F. D. AU - Werner, R. AU - Flom, E. AU - Schmeller, J. AU - Borchert, S. AU - Wessolly, M. PY - 2017 DA - 2017// TI - miRNA regulation is important for DNA damage repair and recognition in malignant pleural mesothelioma JO - Virchows Arch VL - 470 UR - https://doi.org/10.1007/s00428-017-2133-z DO - 10.1007/s00428-017-2133-z ID - Mairinger2017 ER - TY - JOUR AU - Turkcu, G. AU - AlabalIk, U. AU - Keles, A. N. AU - Ibiloglu, I. AU - Kucukoner, M. AU - Sen, H. S. PY - 2016 DA - 2016// TI - Comparison of SKIP expression in malignant pleural mesotheliomas with Ki-67 proliferation index and prognostic parameters JO - Pol J Pathol VL - 67 UR - https://doi.org/10.5114/pjp.2016.61445 DO - 10.5114/pjp.2016.61445 ID - Turkcu2016 ER - TY - JOUR AU - Montanaro, F. AU - Rosato, R. AU - Gangemi, M. AU - Roberti, S. AU - Ricceri, F. AU - Merler, E. PY - 2009 DA - 2009// TI - Survival of pleural malignant mesothelioma in Italy: a population-based study JO - Int J Cancer VL - 124 UR - https://doi.org/10.1002/ijc.23874 DO - 10.1002/ijc.23874 ID - Montanaro2009 ER - TY - JOUR AU - Borasio, P. AU - Berruti, A. AU - Bille, A. AU - Lausi, P. AU - Levra, M. G. AU - Giardino, R. PY - 2008 DA - 2008// TI - Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients JO - Eur J Cardiothorac Surg VL - 33 UR - https://doi.org/10.1016/j.ejcts.2007.09.044 DO - 10.1016/j.ejcts.2007.09.044 ID - Borasio2008 ER - TY - JOUR AU - Christoph, D. C. AU - Eberhardt, W. E. PY - 2014 DA - 2014// TI - Systemic treatment of malignant pleural mesothelioma: new agents in clinical trials raise hope of relevant improvements JO - Curr Opin Oncol VL - 26 UR - https://doi.org/10.1097/CCO.0000000000000053 DO - 10.1097/CCO.0000000000000053 ID - Christoph2014 ER - TY - JOUR AU - Boons, C. C. AU - MW, V. A. N. T. AU - Burgers, J. A. AU - Beckeringh, J. J. AU - Wagner, C. AU - Hugtenburg, J. G. PY - 2013 DA - 2013// TI - The value of pemetrexed for the treatment of malignant pleural mesothelioma: a comprehensive review JO - Anticancer Res VL - 33 ID - Boons2013 ER - TY - JOUR AU - Christoph, D. C. AU - Asuncion, B. R. AU - Mascaux, C. AU - Tran, C. AU - Lu, X. AU - Wynes, M. W. PY - 2012 DA - 2012// TI - Folylpoly-glutamate synthetase expression is associated with tumor response and outcome from pemetrexed-based chemotherapy in malignant pleural mesothelioma JO - J Thorac Oncol VL - 7 UR - https://doi.org/10.1097/JTO.0b013e318260deaa DO - 10.1097/JTO.0b013e318260deaa ID - Christoph2012 ER - TY - BOOK AU - Walter, R. F. PY - 2014 DA - 2014// TI - Molecular biological analysis of malignant pleural mesothelioma [dissertation] PB - Ruhrlandklinik, west German lung Centre, At the university hospital Essen – university hospital: university Duisburg-Essen CY - Essen ID - Walter2014 ER - TY - JOUR AU - Lord, C. J. AU - Ashworth, A. PY - 2016 DA - 2016// TI - BRCAness revisited JO - Nat Rev Cancer VL - 16 UR - https://doi.org/10.1038/nrc.2015.21 DO - 10.1038/nrc.2015.21 ID - Lord2016 ER - TY - JOUR AU - Srinivasan, G. AU - Sidhu, G. S. AU - Williamson, E. A. AU - Jaiswal, A. S. AU - Najmunnisa, N. AU - Wilcoxen, K. PY - 2017 DA - 2017// TI - Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition JO - Cancer Chemother Pharmacol VL - 80 UR - https://doi.org/10.1007/s00280-017-3401-y DO - 10.1007/s00280-017-3401-y ID - Srinivasan2017 ER - TY - JOUR AU - Rottenberg, S. AU - Jaspers, J. E. AU - Kersbergen, A. AU - Burg, E. AU - Nygren, A. O. AU - Zander, S. A. PY - 2008 DA - 2008// TI - High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs JO - Proc Natl Acad Sci U S A VL - 105 UR - https://doi.org/10.1073/pnas.0806092105 DO - 10.1073/pnas.0806092105 ID - Rottenberg2008 ER - TY - JOUR AU - Menear, K. A. AU - Adcock, C. AU - Boulter, R. AU - Cockcroft, X. L. AU - Copsey, L. AU - Cranston, A. PY - 2008 DA - 2008// TI - 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin- 1-one: a novel bioavailable inhibitor of poly (ADP-ribose) polymerase-1 JO - J Med Chem VL - 51 UR - https://doi.org/10.1021/jm8001263 DO - 10.1021/jm8001263 ID - Menear2008 ER - TY - JOUR AU - Parrotta, R. AU - Okonska, A. AU - Ronner, M. AU - Weder, W. AU - Stahel, R. AU - Penengo, L. PY - 2017 DA - 2017// TI - A novel BRCA1-associated Protein-1 isoform affects response of mesothelioma cells to drugs impairing BRCA1-mediated DNA repair JO - J Thorac Oncol VL - 12 UR - https://doi.org/10.1016/j.jtho.2017.03.023 DO - 10.1016/j.jtho.2017.03.023 ID - Parrotta2017 ER - TY - JOUR AU - Fong, P. C. AU - Boss, D. S. AU - Yap, T. A. AU - Tutt, A. AU - Wu, P. AU - Mergui-Roelvink, M. PY - 2009 DA - 2009// TI - Inhibition of poly (ADP-ribose) polymerase in tumors from BRCA mutation carriers JO - N Engl J Med VL - 361 UR - https://doi.org/10.1056/NEJMoa0900212 DO - 10.1056/NEJMoa0900212 ID - Fong2009 ER - TY - JOUR AU - Galateau-Salle, F. AU - Churg, A. AU - Roggli, V. AU - Travis, W. D. PY - 2016 DA - 2016// TI - World Health Organization Committee for tumors of the P. The 2015 World Health Organization classification of tumors of the pleura: advances since the 2004 classification JO - J Thorac Oncol VL - 11 UR - https://doi.org/10.1016/j.jtho.2015.11.005 DO - 10.1016/j.jtho.2015.11.005 ID - Galateau-Salle2016 ER - TY - JOUR AU - Patriarca, S. AU - Ferretti, S. AU - Zanetti, R. PY - 2017 DA - 2017// TI - TNM classification of malignant tumours - eighth edition: which news? JO - Epidemiol Prev VL - 41 ID - Patriarca2017 ER - TY - JOUR AU - Byrne, M. J. AU - Nowak, A. K. PY - 2004 DA - 2004// TI - Modified RECIST criteria for assessment of response in malignant pleural mesothelioma JO - Ann Oncol VL - 15 UR - https://doi.org/10.1093/annonc/mdh059 DO - 10.1093/annonc/mdh059 ID - Byrne2004 ER - TY - JOUR AU - Mairinger, F. D. AU - Schmeller, J. AU - Borchert, S. AU - Wessolly, M. AU - Mairinger, E. AU - Kollmeier, J. PY - 2018 DA - 2018// TI - Immunohistochemically detectable metallothionein expression in malignant pleural mesotheliomas is strongly associated with early failure to platin-based chemotherapy JO - Oncotarget VL - 9 UR - https://doi.org/10.18632/oncotarget.24962 DO - 10.18632/oncotarget.24962 ID - Mairinger2018 ER - TY - JOUR AU - Walter, R. F. AU - Vollbrecht, C. AU - Werner, R. AU - Mairinger, T. AU - Schmeller, J. AU - Flom, E. PY - 2016 DA - 2016// TI - Screening of pleural mesotheliomas for DNA-damage repair players by digital gene expression analysis can enhance clinical Management of Patients Receiving Platin-Based Chemotherapy JO - J Cancer VL - 7 UR - https://doi.org/10.7150/jca.16390 DO - 10.7150/jca.16390 ID - Walter2016 ER - TY - JOUR AU - Wessolly, M. AU - Walter, R. F. H. AU - Vollbrecht, C. AU - Werner, R. AU - Borchert, S. AU - Schmeller, J. PY - 2018 DA - 2018// TI - Processing escape mechanisms through altered proteasomal cleavage of epitopes affect immune response in pulmonary neuroendocrine tumors JO - Technol Cancer Res Treat VL - 17 UR - https://doi.org/10.1177/1533033818818418 DO - 10.1177/1533033818818418 ID - Wessolly2018 ER - TY - JOUR AU - Tutt, A. AU - Bertwistle, D. AU - Valentine, J. AU - Gabriel, A. AU - Swift, S. AU - Ross, G. PY - 2001 DA - 2001// TI - Mutation in Brca2 stimulates error-prone homology-directed repair of DNA double-strand breaks occurring between repeated sequences JO - EMBO J VL - 20 UR - https://doi.org/10.1093/emboj/20.17.4704 DO - 10.1093/emboj/20.17.4704 ID - Tutt2001 ER - TY - JOUR AU - Xia, F. AU - Taghian, D. G. AU - DeFrank, J. S. AU - Zeng, Z. C. AU - Willers, H. AU - Iliakis, G. PY - 2001 DA - 2001// TI - Deficiency of human BRCA2 leads to impaired homologous recombination but maintains normal nonhomologous end joining JO - Proc Natl Acad Sci U S A VL - 98 UR - https://doi.org/10.1073/pnas.151253498 DO - 10.1073/pnas.151253498 ID - Xia2001 ER - TY - JOUR AU - Moynahan, M. E. AU - Pierce, A. J. AU - Jasin, M. PY - 2001 DA - 2001// TI - BRCA2 is required for homology-directed repair of chromosomal breaks JO - Mol Cell VL - 7 UR - https://doi.org/10.1016/S1097-2765(01)00174-5 DO - 10.1016/S1097-2765(01)00174-5 ID - Moynahan2001 ER - TY - JOUR AU - Lord, C. J. AU - Ashworth, A. PY - 2012 DA - 2012// TI - The DNA damage response and cancer therapy JO - Nature VL - 481 UR - https://doi.org/10.1038/nature10760 DO - 10.1038/nature10760 ID - Lord2012 ER - TY - JOUR AU - Turner, N. AU - Tutt, A. AU - Ashworth, A. PY - 2004 DA - 2004// TI - Hallmarks of ‘BRCAness’ in sporadic cancers JO - Nat Rev Cancer VL - 4 UR - https://doi.org/10.1038/nrc1457 DO - 10.1038/nrc1457 ID - Turner2004 ER - TY - JOUR AU - Betti, M. AU - Casalone, E. AU - Ferrante, D. AU - Aspesi, A. AU - Morleo, G. AU - Biasi, A. PY - 2017 DA - 2017// TI - Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma JO - Cancer Lett VL - 405 UR - https://doi.org/10.1016/j.canlet.2017.06.028 DO - 10.1016/j.canlet.2017.06.028 ID - Betti2017 ER - TY - JOUR AU - Rienzo, A. AU - Balsara, B. R. AU - Apostolou, S. AU - Jhanwar, S. C. AU - Testa, J. R. PY - 2001 DA - 2001// TI - Loss of heterozygosity analysis defines a 3-cM region of 15q commonly deleted in human malignant mesothelioma JO - Oncogene VL - 20 UR - https://doi.org/10.1038/sj.onc.1204828 DO - 10.1038/sj.onc.1204828 ID - Rienzo2001 ER - TY - JOUR AU - Patel, K. J. AU - Joenje, H. PY - 2007 DA - 2007// TI - Fanconi anemia and DNA replication repair JO - DNA Repair (Amst) VL - 6 UR - https://doi.org/10.1016/j.dnarep.2007.02.002 DO - 10.1016/j.dnarep.2007.02.002 ID - Patel2007 ER - TY - JOUR AU - D'Andrea, A. D. AU - Grompe, M. PY - 2003 DA - 2003// TI - The Fanconi anaemia/BRCA pathway JO - Nat Rev Cancer VL - 3 UR - https://doi.org/10.1038/nrc970 DO - 10.1038/nrc970 ID - D'Andrea2003 ER - TY - JOUR AU - Roe, O. D. AU - Anderssen, E. AU - Sandeck, H. AU - Christensen, T. AU - Larsson, E. AU - Lundgren, S. PY - 2010 DA - 2010// TI - Malignant pleural mesothelioma: genome-wide expression patterns reflecting general resistance mechanisms and a proposal of novel targets JO - Lung Cancer VL - 67 UR - https://doi.org/10.1016/j.lungcan.2009.03.016 DO - 10.1016/j.lungcan.2009.03.016 ID - Roe2010 ER - TY - JOUR AU - Luca, P. AU - Moiola, C. P. AU - Zalazar, F. AU - Gardner, K. AU - Vazquez, E. S. AU - Siervi, A. PY - 2013 DA - 2013// TI - BRCA1 and p53 regulate critical prostate cancer pathways JO - Prostate Cancer Prostatic Dis VL - 16 UR - https://doi.org/10.1038/pcan.2013.12 DO - 10.1038/pcan.2013.12 ID - Luca2013 ER - TY - JOUR AU - Barakat, B. M. AU - Wang, Q. E. AU - Han, C. AU - Milum, K. AU - Yin, D. T. AU - Zhao, Q. PY - 2010 DA - 2010// TI - Overexpression of DDB2 enhances the sensitivity of human ovarian cancer cells to cisplatin by augmenting cellular apoptosis JO - Int J Cancer VL - 127 ID - Barakat2010 ER - TY - JOUR AU - Zhang, M. AU - Liu, G. AU - Xue, F. AU - Edwards, R. AU - Sood, A. K. AU - Zhang, W. PY - 2016 DA - 2016// TI - Copy number deletion of RAD50 as predictive marker of BRCAness and PARP inhibitor response in BRCA wild type ovarian cancer JO - Gynecol Oncol VL - 141 UR - https://doi.org/10.1016/j.ygyno.2016.01.004 DO - 10.1016/j.ygyno.2016.01.004 ID - Zhang2016 ER - TY - JOUR AU - Bott, M. AU - Brevet, M. AU - Taylor, B. S. AU - Shimizu, S. AU - Ito, T. AU - Wang, L. PY - 2011 DA - 2011// TI - The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma JO - Nat Genet VL - 43 UR - https://doi.org/10.1038/ng.855 DO - 10.1038/ng.855 ID - Bott2011 ER - TY - JOUR AU - Testa, J. R. AU - Cheung, M. AU - Pei, J. AU - Below, J. E. AU - Tan, Y. AU - Sementino, E. PY - 2011 DA - 2011// TI - Germline BAP1 mutations predispose to malignant mesothelioma JO - Nat Genet VL - 43 UR - https://doi.org/10.1038/ng.912 DO - 10.1038/ng.912 ID - Testa2011 ER - TY - JOUR AU - Emri, S. A. PY - 2017 DA - 2017// TI - The Cappadocia mesothelioma epidemic: its influence in Turkey and abroad JO - Ann Transl Med. VL - 5 UR - https://doi.org/10.21037/atm.2017.04.06 DO - 10.21037/atm.2017.04.06 ID - Emri2017 ER - TY - JOUR AU - Singh, A. AU - Pruett, N. AU - Hoang, C. D. PY - 2017 DA - 2017// TI - In vitro experimental models of mesothelioma revisited JO - Transl Lung Cancer Res VL - 6 UR - https://doi.org/10.21037/tlcr.2017.04.12 DO - 10.21037/tlcr.2017.04.12 ID - Singh2017 ER - TY - JOUR AU - Shukla, A. AU - Barrett, T. F. AU - MacPherson, M. B. AU - Hillegass, J. M. AU - Fukagawa, N. K. AU - Swain, W. A. PY - 2011 DA - 2011// TI - An extracellular signal-regulated kinase 2 survival pathway mediates resistance of human mesothelioma cells to asbestos-induced injury JO - Am J Respir Cell Mol Biol VL - 45 UR - https://doi.org/10.1165/rcmb.2010-0282OC DO - 10.1165/rcmb.2010-0282OC ID - Shukla2011 ER - TY - STD TI - Database GHG. www.genecards.org. Accessed 20 June 2018. UR - http://www.genecards.org ID - ref40 ER -